National Research Council Canada
Symbol of the Government of Canada
Dimensions

ARCHIVED - Video of the Biomedical Technologies Cluster Initiative in Winnipeg, Manitoba

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.


With sales of more than $400 million a year and dramatic growth since the early 1990s, the Winnipeg biomedical technologies cluster has become recognized around the world for its medical devices and life sciences industries. Today, the cluster is poised to take on larger, international markets and opportunities.

Learn more about Winnipeg's biomedical technologies cluster (via NRC corporate website).

Video preview image

Video length: 2:03 min
Important Notices

Video Transcript

Narrator: Cutting edge medical devices of the future are being developed now in the Biomedical Technology cluster initiative, located in Winnipeg.

The cluster is a thriving concentration of university researchers and life science companies which generates impressive economic opportunities. It's supported and guided by the National Research Council's Institute for Biodiagnostics.

Much of the work focuses on advanced imaging of neurological disorders. NRC's biomedical testing and development includes new technologies that are actually able to scan patients while they are in surgery.

Harry Schulz (Chief Innovation Officer, Winnipeg Regional Health Authority): This is about better patient care, ultimately. It is about economic development and building new Canadian innovation capacity and taking some of the things that are on the lab bench and some of our research settings and introducing them into the medical product marketplace.

Narrator: NRC lends support to small and medium size enterprises such as Koven Technologies. Its newest product is a device which safely removes blockages from inside of arteries.

Ian Maclean (Project Manager, Koven Technology Canada): It really allows companies like Koven, small companies, to get some of the upfront initial business and market planning and technical assessment of our product before we go out and spend a lot more money to develop it. That's a real benefit.

Narrator: NRC's team-based approach results in a constant transfer of information between cluster partners on advanced technologies. This provides new tools, greater revenues and better health care for Canadians.

For more information on the biomedical technology cluster, please visit nrc.gc.ca.

A message from the Government of Canada. End